<DOC>
	<DOCNO>NCT01761929</DOCNO>
	<brief_summary>This prospective Phase II study.The purpose study monitor side effect treatment outcomes deliver high dos radiation therapy tumour , limit dose radiation normal tissue . This do use 5 day treatment schedule . The characteristic patient whose disease remain confine limited area long term , compare also describe .</brief_summary>
	<brief_title>5 Fraction Stereotactic Body Radiation Therapy Oligometastases Regimen , Extra-Cranial Oligometastases</brief_title>
	<detailed_description>Endpoints describe : proportion patient local control index site 1 year ; number index lesion ( ) local control 1 year ; acute late AEs related SBRT ; time local progression index site ; time distant disease progression ; symptom QoL profile ; median survival .</detailed_description>
	<criteria>Any solid tumor eligible . Lymphoma , myeloma germ cell tumor exclude . Histological confirmation neoplastic disease either original primary metastatic site require . Radiological diagnosis oligometastastic metastatic disease accept consider clinically acceptable . Histological confirmation mandatory . Oligometastatic disease , maximum 5 lesion . At least one lesion suitable stereotactic body radiotherapy All know site disease plan local ablative management ( see section management plan definition ) within 3 month ECOG â‰¤ 2 At least 18 yr old Previous radiotherapy intend treatment site Patient tolerate physical set require SBRT Active bowel obstruction , treat abdominal/pelvic site Chemotherapy within 2 week intend radiation therapy Treatment plan respect normal tissue tolerance use dose fractionation specify within protocol achieve Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>oligometastatic</keyword>
	<keyword>oligometastases</keyword>
	<keyword>stereotactic body radiotherapy</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>Oligometastasis</keyword>
	<keyword>Stereotactic ablative body</keyword>
	<keyword>radiotherapy</keyword>
</DOC>